𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enoxaparin is a cost-effective adjunct to fibrinolytic therapy for ST-elevation myocardial infarction in contemporary practice

✍ Scribed by Ian Menown; Gilles Montalescot; Nikhal Pal; Carrie Fidler; Michelle Orme; Samantha Gillard

Book ID
107648645
Publisher
Springer Healthcare Communications
Year
2010
Tongue
English
Weight
316 KB
Volume
27
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of pretreatment with clopidogrel
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: A Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study
✍ C. Michael Gibson; Sabina A. Murphy; Yuri B. Pride; Ajay J. Kirtane; Julian M. A πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 182 KB
Cost-effectiveness of enoxaparin compare
Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial
✍ Robert C. Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; William S. Weintraub; Pier πŸ“‚ Article πŸ“… 2009 πŸ› Pulsus Group Inc 🌐 English βš– 709 KB